Innoviva, Inc. insider trades
Innoviva, Inc. has filed 1 Form 4 with the SEC that we hold, all for Armata Pharmaceuticals, Inc. (ARMP), as Director, 10% owner. Across all of them we count 1 purchase worth $26.9M and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 5,385,208 shares of Armata Pharmaceuticals, Inc. worth $26.9M, dated 2022-03-31. The first filing on our record is dated 2022-04-01 and the latest 2022-04-01.
Armata Pharmaceuticals, Inc. (ARMP)
Director, 10% owner · 1 filing · 1 purchase or sale
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-03-31 | P, purchase reported on Form 4 | 5,385,208 | $26.9M | 2022-04-01 | SEC |
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 1080014) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
